David Geffen School of Medicine at the University of California, Los Angeles, California, USA.
Department of Neurosurgery, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Epilepsia. 2024 Jan;65(1):57-72. doi: 10.1111/epi.17807. Epub 2023 Nov 11.
Hemimegalencephaly (HME) is a rare congenital brain malformation presenting predominantly with drug-resistant epilepsy. Hemispheric disconnective surgery is the mainstay of treatment; however, little is known about how postoperative outcomes compare across techniques. Thus we present the largest single-center cohort of patients with HME who underwent epilepsy surgery and characterize outcomes.
This observational study included patients with HME at University of California Los Angeles (UCLA) from 1984 to 2021. Patients were stratified by surgical intervention: anatomic hemispherectomy (AH), functional hemispherectomy (FH), or less-than-hemispheric resection (LTH). Seizure freedom, functional outcomes, and operative complications were compared across surgical approaches. Regression analysis identified clinical and intraoperative variables that predict seizure outcomes.
Of 56 patients, 43 (77%) underwent FH, 8 (14%) underwent AH, 2 (4%) underwent LTH, 1 (2%) underwent unknown hemispherectomy type, and 2 (4%) were managed non-operatively. At median last follow-up of 55 months (interquartile range [IQR] 20-92 months), 24 patients (49%) were seizure-free, 17 (30%) required cerebrospinal fluid (CSF) shunting for hydrocephalus, 9 of 43 (21%) had severe developmental delay, 8 of 38 (21%) were non-verbal, and 15 of 38 (39%) were non-ambulatory. There was one (2%) intraoperative mortality due to exsanguination earlier in this cohort. Of 12 patients (29%) requiring revision surgery, 6 (50%) were seizure-free postoperatively. AH, compared to FH, was not associated with statistically significant improved seizure freedom (hazard ratio [HR] = .48, p = .328), although initial AH trended toward greater odds of seizure freedom (75% vs 46%, p = .272). Younger age at seizure onset (HR = .29, p = .029), lack of epilepsia partialis continua (EPC) (HR = .30, p = .022), and no contralateral seizures on electroencephalography (EEG) (HR = .33, p = .039) independently predicted longer duration of seizure freedom.
This study helps inform physicians and parents of children who are undergoing surgery for HME by demonstrating that earlier age at seizure onset, absence of EPC, and no contralateral EEG seizures were associated with longer postoperative seizure freedom. At our center, initial AH for HME may provide greater odds of seizure freedom with complications and functional outcomes comparable to those of FH.
偏侧巨脑畸形(HME)是一种罕见的先天性脑畸形,主要表现为耐药性癫痫。半球离断术是治疗的主要方法;然而,对于不同技术的术后结果如何比较,我们知之甚少。因此,我们报告了最大的单一中心 HME 患者队列,这些患者接受了癫痫手术,并对结果进行了特征描述。
本观察性研究包括 1984 年至 2021 年在加利福尼亚大学洛杉矶分校(UCLA)接受治疗的 HME 患者。患者按手术干预方式分层:解剖性半脑切除术(AH)、功能性半脑切除术(FH)或非半球切除术(LTH)。比较不同手术方法的癫痫无发作、功能结果和手术并发症。回归分析确定了预测癫痫结果的临床和术中变量。
56 例患者中,43 例(77%)接受 FH,8 例(14%)接受 AH,2 例(4%)接受 LTH,1 例(2%)接受未知类型的半脑切除术,2 例(4%)接受非手术治疗。在中位最后随访 55 个月(四分位距 [IQR] 20-92 个月)时,24 例患者(49%)无癫痫发作,17 例(30%)因脑积水需要脑脊液(CSF)分流,43 例中的 9 例(21%)存在严重发育迟缓,38 例中的 8 例(21%)无法言语,38 例中的 15 例(39%)无法行走。在该队列中,有 1 例(2%)因术中出血而死亡。在需要再次手术的 12 例患者中(29%),6 例(50%)术后无癫痫发作。与 FH 相比,AH 并不能显著提高癫痫无发作的几率(风险比 [HR] = .48,p = .328),尽管初始 AH 有更大的癫痫无发作几率(75%比 46%,p = .272)。发病年龄较小(HR = .29,p = .029)、无部分性癫痫持续状态(EPC)(HR = .30,p = .022)和脑电图(EEG)无对侧癫痫发作(HR = .33,p = .039)独立预测癫痫无发作时间更长。
本研究通过证明发病年龄较小、无 EPC 和无对侧 EEG 癫痫发作与术后癫痫无发作时间较长有关,从而为正在接受 HME 手术的医生和家长提供了帮助。在我们中心,HME 的初始 AH 可能提供更大的癫痫无发作几率,且并发症和功能结果与 FH 相当。